Development and function of FOXP3+ regulators of immune responses
Author:
Affiliation:
1. Department of Immunology, University of Toronto , Toronto, ON , Canada
2. Biological Sciences, Sunnybrook Research Institute , Toronto, ON , Canada
Abstract
Funder
Canadian Institutes of Health Research
Publisher
Oxford University Press (OUP)
Subject
Immunology,Immunology and Allergy
Link
https://academic.oup.com/cei/advance-article-pdf/doi/10.1093/cei/uxad048/50204296/uxad048.pdf
Reference79 articles.
1. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse;Brunkow;Nat Genet,2001
2. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3;Bennett;Nat Genet,2001
3. CD4+CD8- T cells are the effector cells in disease pathogenesis in the scurfy (sf) mouse;Blair;J Immunol,1994
4. Analysis of FoxP3+ T-regulatory cells and CD8+ T-cells in ovarian carcinoma: location and tumor infiltration patterns are key prognostic markers;Hermans;PLoS One,2014
5. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide;Jordan;Nat Immunol,2001
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04
2. Clinical and Experimental Immunology: Highlights of 2023;Clinical and Experimental Immunology;2024-02-27
3. Targeting post-translational modifications of Foxp3: a new paradigm for regulatory T cell-specific therapy;Frontiers in Immunology;2023-10-23
4. Unconventional T cells in chronic disease and as targets of therapy;Clinical and Experimental Immunology;2023-06-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3